237 related articles for article (PubMed ID: 16086042)
1. Donor cell-derived myelodysplastic syndrome in a patient 7 years after unrelated allogeneic HLA-mismatched transplantation for Ph+ chronic myeloid leukemia.
Kraut L; Trebeljahr G; Thiele B; Fauser AA
Bone Marrow Transplant; 2005 Oct; 36(8):737. PubMed ID: 16086042
[No Abstract] [Full Text] [Related]
2. Incidence of hyperthyroidism after unrelated donor allogeneic stem cell transplantation.
Perz JB; Marin D; Szydlo RM; Giles C; Olavarria E; Williams G; Apperley JF
Leuk Res; 2007 Oct; 31(10):1433-6. PubMed ID: 17433437
[TBL] [Abstract][Full Text] [Related]
3. A Philadelphia chromosome positive acute lymphoblastic leukemia of donor origin after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase.
Saito Y; Uzuka Y; Sakai N; Suzuki S; Toyota T
Bone Marrow Transplant; 2000 Jun; 25(11):1209-11. PubMed ID: 10849535
[TBL] [Abstract][Full Text] [Related]
4. [Allogeneic bone marrow transplantation of unrelated donors; fewer complication, more donors].
Liem GS; Cornelissen JJ; Oudshoorn M; Sintnicolaas K; Löwenberg B; Hagenbeek A
Ned Tijdschr Geneeskd; 1997 Aug; 141(32):1553-6. PubMed ID: 9543748
[TBL] [Abstract][Full Text] [Related]
5. Marrow aplasia developing 13 years after HLA-identical sibling allogeneic transplantation for chronic myeloid leukaemia: successful treatment with antithymocyte globulin and peripheral blood stem cell infusion from the original donor.
O'Donghaile D; Hayden PJ; McCarron SL; Doyle EM; Lawler M; Browne PV; Conneally E; Vandenberghe E; McCann SR
Eur J Haematol; 2006 Mar; 76(3):258-60. PubMed ID: 16451399
[TBL] [Abstract][Full Text] [Related]
6. Genotyping analysis of HLA-class II and III genes in unrelated bone marrow transplantation among Japanese. Nagoya Bone Marrow Transplantation Group and Tokai Marrow Donor Bank.
Mizuno S; Ohta H; Kamijima S; Kato Y; Maruya E; Saji H; Kamiya T; Kodera Y; Morishima Y
Transplant Proc; 1995 Feb; 27(1):1383-4. PubMed ID: 7878921
[No Abstract] [Full Text] [Related]
7. Unsuccessful allogeneic and autologous transplants after prolonged interferon-alpha treatment in a pediatric patient with chronic myeloid leukemia.
Pérez-Caballero C; Maldonado MS; Tamariz R; de Oteyza JP; Muñoz A
Haematologica; 2000 Jan; 85(1):105-6. PubMed ID: 10629605
[No Abstract] [Full Text] [Related]
8. Fatal graft-versus-host disease following HLA-mismatched donor lymphocyte infusion.
Amrolia PJ; Rao K; Slater O; Ramsay A; Veys PA; Webb DK
Bone Marrow Transplant; 2001 Sep; 28(6):623-5. PubMed ID: 11607779
[TBL] [Abstract][Full Text] [Related]
9. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L
Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic bone marrow transplantation of chronic myeloid leukemia from an HLA-matched unrelated donor with the beta-thalassemic trait.
Sue YC; Liu TC; Chang CS; Huang SM; Chen TP; Lin SF
Int J Hematol; 1999 Apr; 69(3):200-2. PubMed ID: 10222660
[TBL] [Abstract][Full Text] [Related]
11. Myelofibrosis as the initial presentation of donor-derived myelodysplastic syndrome/AML: failure of a lasting response to a second allogeneic transplant from the original donor.
Cutting RJ; Welch E; Channer J; Ezaydi Y; Talley P; Reilly JT; Snowden JA
Bone Marrow Transplant; 2008 Nov; 42(9):631-3. PubMed ID: 18695662
[No Abstract] [Full Text] [Related]
12. Development of donor cell derived acute myeloid leukemia after stem cell transplantation for chronic myeloid leukemia.
Pieroni F; Oliveira FM; Panepucci RA; Voltarelli JC; Simões BP; Falcão RP
Bone Marrow Transplant; 2006 Apr; 37(8):801-2. PubMed ID: 16501585
[No Abstract] [Full Text] [Related]
13. Donor cell leukemia in a patient developing 11 months after an allogeneic bone marrow transplantation for chronic myeloid leukemia.
Ataergin S; Arpaci F; Cetin T; Guran S; Yakicier C; Beyzadeoglu M; Ozet A
Am J Hematol; 2006 May; 81(5):370-3. PubMed ID: 16628734
[TBL] [Abstract][Full Text] [Related]
14. Acute myeloid leukaemia of donor cell origin developing 5 years after allogeneic bone marrow transplantation for chronic myeloid leukaemia.
Gopcsa L; Barta A; Banyai A; Konya M; Pajor L; Földi J; Paloczi K
Bone Marrow Transplant; 2002 Mar; 29(5):449-52. PubMed ID: 11919736
[TBL] [Abstract][Full Text] [Related]
15. Contemporaneous appearance, 18 years after allogeneic bone marrow transplantation, of myelodysplastic syndrome in the patient and the donor.
Orciuolo E; Azzarà A; Bandini G; Galimberti S; Bonifazi F; Fazzi R; Petrini M
Bone Marrow Transplant; 2004 Apr; 33(8):859-61. PubMed ID: 14743194
[TBL] [Abstract][Full Text] [Related]
16. Essential thrombocythemia after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Khoury H; Adkins D; Zehnbauer B; Goodnough L; Brown R; Safdar S; DiPersio JF
Bone Marrow Transplant; 1998 Jul; 22(1):107-9. PubMed ID: 9678805
[TBL] [Abstract][Full Text] [Related]
17. Rituximab-induced acute liver failure after an allogeneic transplantation for chronic myeloid leukemia.
Qazilbash MH; Qu Z; Hosing C; Couriel D; Donato M; Giralt S; Champlin R
Am J Hematol; 2005 Sep; 80(1):43-5. PubMed ID: 16138357
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy.
Yakoub-Agha I; Mesnil F; Kuentz M; Boiron JM; Ifrah N; Milpied N; Chehata S; Esperou H; Vernant JP; Michallet M; Buzyn A; Gratecos N; Cahn JY; Bourhis JH; Chir Z; Raffoux C; Socié G; Golmard JL; Jouet JP;
J Clin Oncol; 2006 Dec; 24(36):5695-702. PubMed ID: 17116940
[TBL] [Abstract][Full Text] [Related]
19. Transplantation of unrelated cord blood cells.
Weinreb S; Delgado JC; Clavijo OP; Yunis EJ; Bayer-Zwirello L; Polansky L; Deluhery L; Cohn G; Yao JT; Stec TC; Higby D; Anderzejewski C
Bone Marrow Transplant; 1998 Jul; 22(2):193-6. PubMed ID: 9707029
[TBL] [Abstract][Full Text] [Related]
20. Late-onset pure red blood cell aplasia owing to delayed lymphoid engraftment complicating ABO-mismatched hematopoietic stem cell transplantation.
Au WY; Lie AK; Ma ES; Lau GK; Chan EC; Kwong YL
Transfusion; 2004 Jun; 44(6):946-7. PubMed ID: 15157268
[No Abstract] [Full Text] [Related]
[Next] [New Search]
